Credit Suisse’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-233,976
| Closed | -$6.31M | – | 3901 |
|
|
2022
Q4 | $6.31M | Buy |
233,976
+197,360
| +539% | +$5.32M | 0.01% | 1150 |
|
|
2022
Q3 | $657K | Buy |
36,616
+7,709
| +27% | +$138K | ﹤0.01% | 2607 |
|
|
2022
Q2 | $359K | Buy |
28,907
+2,593
| +10% | +$32.2K | ﹤0.01% | 3039 |
|
|
2022
Q1 | $350K | Buy |
26,314
+1,659
| +7% | +$22.1K | ﹤0.01% | 3139 |
|
|
2021
Q4 | $383K | Sell |
24,655
-1,987
| -7% | -$30.9K | ﹤0.01% | 3188 |
|
|
2021
Q3 | $598K | Buy |
26,642
+587
| +2% | +$13.2K | ﹤0.01% | 2896 |
|
|
2021
Q2 | $586K | Sell |
26,055
-6,235
| -19% | -$140K | ﹤0.01% | 2939 |
|
|
2021
Q1 | $664K | Buy |
32,290
+4,777
| +17% | +$98.2K | ﹤0.01% | 2796 |
|
|
2020
Q4 | $760K | Sell |
27,513
-27,786
| -50% | -$768K | ﹤0.01% | 2746 |
|
|
2020
Q3 | $777K | Buy |
55,299
+36,300
| +191% | +$510K | ﹤0.01% | 2431 |
|
|
2020
Q2 | $392K | Sell |
18,999
-11
| -0.1% | -$227 | ﹤0.01% | 2829 |
|
|
2020
Q1 | $143K | Buy |
19,010
+2,808
| +17% | +$21.1K | ﹤0.01% | 3136 |
|
|
2019
Q4 | $251K | Buy |
16,202
+1,318
| +9% | +$20.4K | ﹤0.01% | 3239 |
|
|
2019
Q3 | $78K | Buy |
14,884
+4,744
| +47% | +$24.9K | ﹤0.01% | 3314 |
|
|
2019
Q2 | $92K | Buy |
+10,140
| New | +$92K | ﹤0.01% | 3312 |
|
|
2017
Q3 | – | Sell |
-13,222
| Closed | -$155K | – | 3743 |
|
|
2017
Q2 | $155K | Buy |
+13,222
| New | +$155K | ﹤0.01% | 3280 |
|